107 filings
POS AM
SRNE
Sorrento Therapeutics, Inc.
18 Jul 23
Prospectus update (post-effective amendment)
5:23pm
POS AM
SRNE
Sorrento Therapeutics, Inc.
21 Jun 23
Prospectus update (post-effective amendment)
5:24pm
POS AM
SRNE
Sorrento Therapeutics, Inc.
12 May 23
Prospectus update (post-effective amendment)
5:28pm
25-NSE
The Nasdaq Stock Market LLC
12 Apr 23
Exchange delisting
8:50am
S-8
SRNE
Sorrento Therapeutics, Inc.
16 Dec 22
Registration of securities for employees
9:45pm
425
53ffou48bjkh oud
13 Sep 22
Business combination disclosure
6:15pm
425
hzjzmv6qf6pji
14 Jun 22
Business combination disclosure
2:51pm
425
gt6ce31m
23 May 22
Business combination disclosure
9:06am
425
4aumwsqsxs0rvu
18 Mar 22
Business combination disclosure
9:03am
424B7
xbz hwfghveh
3 Mar 22
Prospectus with selling stockholder info
5:08pm
S-3ASR
7f636a
23 Dec 21
Automatic shelf registration
5:20pm
424B5
1879zu9
3 Dec 21
Prospectus supplement for primary offering
4:33pm
424B3
kybvb0ptvmk1ay08vb
15 Jul 21
Prospectus supplement
5:01pm
424B3
tscbes d6ep9b3l
1 Jun 21
Prospectus supplement
4:59pm
424B3
59cww4e
20 Apr 21
Prospectus supplement
12:00am
424B3
plf8e5n9nps6mml 4o7e
6 Apr 21
Prospectus supplement
12:00am